Controversies in dyslipidaemia management.
European Atherosclerosis Society, Kronhusgatan 11, SE-411 05 Gothenburg, Sweden. office@eas-society.org
Jane
J
Stock
D000293:Adolescent; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000191:economics / Q000628:therapy*; D019317:Evidence-Based Medicine; D005260:Female; D017048:Health Care Costs; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D055815:Young Adult
D015415:Biomarkers; D000960:Hypolipidemic Agents